Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 15, 2023

Crizotinib Plus Chemotherapy for Children With ALK+ Anaplastic Large-Cell Lymphoma

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1
J. Clin. Oncol 2022 Dec 19;[EPub Ahead of Print], EJ Lowe, AF Reilly, MS Lim, TG Gross, L Saguilig, DA Barkauskas, R Wu, S Alexander, CM Bollard

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading